|
ZNF473 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08988382155439E-12 |
| Normal-vs-Stage2 |
7.46949999963498E-07 |
| Normal-vs-Stage3 |
2.26263452418607E-13 |
| Normal-vs-Stage4 |
2.96718205561319E-12 |
| Stage1-vs-Stage2 |
3.993800E-01 |
| Stage1-vs-Stage3 |
1.900400E-01 |
| Stage1-vs-Stage4 |
2.747600E-02 |
| Stage2-vs-Stage3 |
7.164000E-02 |
| Stage2-vs-Stage4 |
1.482320E-02 |
| Stage3-vs-Stage4 |
4.050200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13020703906841E-13 |
| Normal-vs-AfricanAmerican |
1.98419999986044E-07 |
| Normal-vs-Asian |
5.06470000383175E-08 |
| Caucasian-vs-AfricanAmerican |
5.366400E-01 |
| Caucasian-vs-Asian |
9.748400E-02 |
| AfricanAmerican-vs-Asian |
7.105600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03521660530259E-12 |
| Normal-vs-Female |
1.62914126633495E-12 |
| Male-vs-Female |
8.808200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.21559454011344E-11 |
| Normal-vs-Age(41-60Yrs) |
1.27880039890726E-10 |
| Normal-vs-Age(61-80Yrs) |
1.54359858228759E-11 |
| Normal-vs-Age(81-100Yrs) |
1.311810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.098000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.304400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.955200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.633200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.451200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.162800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.367500E-04 |
| Classical-VS-Follicular |
7.663400E-01 |
| Classical-VS-Other |
4.414400E-02 |
| Classical-VS-Normal |
1.10260001129348E-09 |
| Tall-VS-Follicular |
3.317900E-02 |
| Tall-VS-Other |
5.265600E-01 |
| Tall-VS-Normal |
6.49813536313104E-13 |
| Follicular-VS-Other |
2.653400E-01 |
| Follicular-VS-Normal |
1.35519999999723E-07 |
| Other-VS-Normal |
9.67370000000134E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.61772850460329E-14 |
| Normal-vs-N1 |
1.81021864165132E-12 |
| N0-vs-N1 |
8.319000E-03 |
|
|
